ES2091816T3 - Anticuerpos monoclonales del factor estimulador de colonias de macrofagos (m-csf) que reconocen un epitope conformacional neutralizante. - Google Patents

Anticuerpos monoclonales del factor estimulador de colonias de macrofagos (m-csf) que reconocen un epitope conformacional neutralizante.

Info

Publication number
ES2091816T3
ES2091816T3 ES90902943T ES90902943T ES2091816T3 ES 2091816 T3 ES2091816 T3 ES 2091816T3 ES 90902943 T ES90902943 T ES 90902943T ES 90902943 T ES90902943 T ES 90902943T ES 2091816 T3 ES2091816 T3 ES 2091816T3
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
csf
conformational epitope
macrophagus
recognizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90902943T
Other languages
English (en)
Inventor
Robert F Halenbeck
Kirston E Koths
Joseph W Wrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cetus Oncology Corp
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Application granted granted Critical
Publication of ES2091816T3 publication Critical patent/ES2091816T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBEN ANTICUERPOS MONOCLONALES, Y SUS METODOS DE UTILIZACION, QUE SE UNEN A UN EPITOPE CONFORMACIONAL APARENTE ASOCIADO CON M-CSF DIMERICO RECOMBINANTE O INNATO CON NEUTRALIZACION CONCOMITANTE DE ACTIVIDAD BIOLOGICA, ESTOS ANTICUERPOS MONOCLONALES SON SUSTANCIALMENTE NO REACTIVOS CON FORMAS INACTIVAS DE M-CSF INCLUYENDO M-CSF DIMERICO DERIVATIZADO QUIMICAMENTE Y MONOMERICO.
ES90902943T 1989-02-10 1990-01-17 Anticuerpos monoclonales del factor estimulador de colonias de macrofagos (m-csf) que reconocen un epitope conformacional neutralizante. Expired - Lifetime ES2091816T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31004289A 1989-02-10 1989-02-10

Publications (1)

Publication Number Publication Date
ES2091816T3 true ES2091816T3 (es) 1996-11-16

Family

ID=23200753

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90902943T Expired - Lifetime ES2091816T3 (es) 1989-02-10 1990-01-17 Anticuerpos monoclonales del factor estimulador de colonias de macrofagos (m-csf) que reconocen un epitope conformacional neutralizante.

Country Status (9)

Country Link
US (1) US5491065A (es)
EP (1) EP0457804B1 (es)
JP (1) JP3001969B2 (es)
AT (1) ATE141290T1 (es)
CA (1) CA2008817C (es)
DE (1) DE69028095T2 (es)
DK (1) DK0457804T3 (es)
ES (1) ES2091816T3 (es)
WO (1) WO1990009400A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096540A (en) * 1996-09-30 2000-08-01 Becton Dickinson And Company Differentiation of granulocytic and monocytic progenitor cells
US6363129B1 (en) 1998-11-09 2002-03-26 Broadcom Corporation Timing recovery system for a multi-pair gigabit transceiver
AU1759501A (en) * 1999-11-08 2001-06-06 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Method of treating a viral infection using antagonists of macrophage colony stimulating factor
US7108852B2 (en) * 2000-03-20 2006-09-19 Warner-Lambert Company Llc Methods of treating inflammation using antibodies to M-CSF
US20110091451A1 (en) * 2002-11-15 2011-04-21 Kavanaugh William M Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
JP4727992B2 (ja) * 2002-11-15 2011-07-20 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 癌転移および癌転移に伴なう骨量減少を予防および処置するための方法
AR045563A1 (es) * 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
DK2311873T3 (en) 2004-01-07 2018-11-26 Novartis Vaccines & Diagnostics Inc M-CSF-SPECIFIC MONOCLONAL ANTIBODY AND APPLICATIONS THEREOF
CA2570296A1 (en) * 2004-06-12 2005-12-29 Oregon Health And Science University Compositions and methods for diagnosis and treatment of orthopoxviruses
US20090117103A1 (en) * 2005-03-08 2009-05-07 Pharmacia & Upjohn Company Llc M-CSF Antibody compositions Having Reduced Levels of Endotoxin
EP2311876A3 (en) * 2005-07-28 2011-04-27 Novartis AG M-CSF-specific monoclonal antibody and uses thereof
EP2277916A3 (en) * 2005-07-28 2011-04-27 Novartis AG Use of antibody to M-CSF
EP1984024A2 (en) 2006-01-05 2008-10-29 Novartis AG Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
US9243066B2 (en) 2011-07-18 2016-01-26 University Of Melbourne Use of M-CSF antibodies in the treatment of osteoarthritis or pain
WO2014167088A1 (en) 2013-04-12 2014-10-16 Morphosys Ag Antibodies targeting m-csf

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504586A (en) * 1983-02-03 1985-03-12 Amgen Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
MX9203130A (es) * 1986-05-06 1992-07-01 Genetics Inst Produccion de m-csf
GB8624899D0 (en) * 1986-10-17 1986-11-19 Sandoz Ltd Monoclonal antibodies
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1

Also Published As

Publication number Publication date
EP0457804B1 (en) 1996-08-14
ATE141290T1 (de) 1996-08-15
CA2008817C (en) 2000-03-14
JP3001969B2 (ja) 2000-01-24
WO1990009400A1 (en) 1990-08-23
JPH04503155A (ja) 1992-06-11
DE69028095D1 (de) 1996-09-19
EP0457804A1 (en) 1991-11-27
DK0457804T3 (da) 1996-09-23
DE69028095T2 (de) 1997-02-06
US5491065A (en) 1996-02-13
CA2008817A1 (en) 1990-08-10

Similar Documents

Publication Publication Date Title
ES2091816T3 (es) Anticuerpos monoclonales del factor estimulador de colonias de macrofagos (m-csf) que reconocen un epitope conformacional neutralizante.
ES2109228T3 (es) Anticuerpos monoclonales mejorados contra el receptor de las celulas t alfa/beta humano, su produccion y uso.
ES2115626T3 (es) Anticuerpo monoclonal humano especifico al antigeno de superficie de la membrana de las celulas cancerosas.
DE69233191D1 (de) Cyclin d1 und seine cdna
ATE279514T1 (de) Vorläufer von für tumorabstossung verantwortlichen antigenen, die antigene und deren verwendungen
SE7512192L (sv) Cancerantigen, cancerterapi och cancerdiagnostikum
ES2053413T1 (es) Peptidos que inducen anticuerpos que neutralizan aislados de vih-1 geneticamente divergentes.
ES2130121T3 (es) Antigeno intra-acrosomico de esperma humano para uso en una vacuna anticonceptiva.
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
ATE61228T1 (de) Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff.
ES2145004T3 (es) Derivados de anticuerpos.
EP0671920A4 (en) AN ANTI-IDIOTYPICAL ANTIBODY AND ITS USE IN THE DIAGNOSIS AND THERAPY OF HIV-RELATED DISEASES.
ES2065303T3 (es) Procedimiento de diagnosis y vacuna especifica.
ES2231826T3 (es) Anticuerpos monoclonales anti-cd6 para el tratamiento y el diagnostico de la psoriasis.
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
DE9321535U1 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper
ES2054667T3 (es) Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso.
ES2123558T3 (es) Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc.
PE20220708A1 (es) Anticuerpos anti-cd73
ES2194836T3 (es) Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
ES2115622T5 (es) Clones moleculares de hiv-1 y usos de los mismos.
AR246310A1 (es) Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.
ES2064349T3 (es) Inmunoglobulinas humanas especificas del antigeno relacionado con el cancer e hibridomas humanos-humanos que pueden producir estas inmunoglobulinas humanas.
ES2104600T3 (es) Polipeptido que tiene actividad del factor quimiotactico de los monocitos humanos y adn que codifica dicho polipeptido.
DE69841331D1 (de) Humanisierte monoklonale antikörper die schützen gegen shigatoxininduzierte krankheiten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 457804

Country of ref document: ES